WW International (NASDAQ:WW) Posts Earnings Results

Key Points

• WW International missed earnings for the quarter, posting an EPS of ($5.20) versus analyst expectations of ($2.45), though revenue came in above estimates at $168.26 million.
• Clinical/Med+ subscriptions are growing quickly, with end-of-period clinical subscribers reaching 197,000 and clinical subscription revenue up 32% year over year, even as the broader behavioral subscriber base declined.
• The company reaffirmed its 2026 outlook for revenue of $620 million to $635 million and adjusted EBITDA of $105 million to $115 million, and said it expects to generate cash in 2026 while using $37 million in Q2 to pay down debt.

WW International (NASDAQ:WW - Get Free Report) announced its earnings results on Thursday. The company reported ($5.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.45) by ($2.75), FiscalAI reports. The business had revenue of $168.26 million for the quarter, compared to analysts' expectations of $158.53 million.

Here are the key takeaways from WW International's conference call:

• Clinical (Med+) momentum — end-of-period clinical subscribers reached 197,000 (51% sequential growth) and clinical subscription revenue rose 32% year‑over‑year; clinical ARPU remains >4x behavioral and management expects clinical to be ~25–30% of 2026 revenue.
• Behavioral subscriber base continues to shrink — end-of-period behavioral subscribers were 2.5 million, down 25% year‑over‑year, contributing to Q1 revenue of $168 million, a 10% decline versus prior year.
• Company reaffirmed 2026 guidance (revenue $620–$635M; adjusted EBITDA $105–$115M), expects to generate cash in 2026, and will use $37 million in Q2 to reduce term‑loan principal, cutting ~$4 million of annual interest.
• Strategic positioning around GLP‑1s — management highlighted that combining FDA‑approved medications with WW behavioral support drives stronger outcomes (Med+ members in GLP‑1 Success lost 29.1% more body weight at 12 months) and sees orals/affordability expanding the addressable market.
• Margins and spending are mixed — Q1 adjusted gross margin stayed near a record at 73.6% despite a clinical mix shift, but marketing was front‑loaded at $93M and management expects modest gross‑margin pressure in 2026 while marketing as a percent of revenue increases slightly.

WW International Stock Performance

Shares of WW International stock traded up $1.03 on Friday, reaching $10.20. 663,673 shares of the stock were exchanged, compared to its average volume of 347,018. The firm's 50 day moving average is $15.33 and its 200-day moving average is $22.64. WW International has a one year low of $8.36 and a one year high of $46.95. The firm has a market cap of $101.99 million, a PE ratio of -1.76 and a beta of 1.30.

Analyst Ratings Changes

WW has been the topic of a number of analyst reports. Zacks Research upgraded shares of WW International from a "strong sell" rating to a "hold" rating in a research report on Monday, March 16th. Weiss Ratings restated a "sell (d+)" rating on shares of WW International in a research report on Friday, January 9th. Three investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce".

Institutional Trading of WW International

Institutional investors and hedge funds have recently made changes to their positions in the company. Ameriprise Financial Inc. bought a new stake in shares of WW International during the 3rd quarter worth approximately $623,000. Quinn Opportunity Partners LLC bought a new stake in shares of WW International during the 4th quarter worth approximately $1,010,000. Marshall Wace LLP bought a new stake in shares of WW International during the 4th quarter worth approximately $1,108,000. Geode Capital Management LLC lifted its holdings in shares of WW International by 3.9% during the 4th quarter. Geode Capital Management LLC now owns 113,610 shares of the company's stock worth $3,321,000 after acquiring an additional 4,251 shares during the period. Finally, Cooper Creek Partners Management LLC bought a new stake in shares of WW International during the 3rd quarter worth approximately $3,336,000. Institutional investors own 86.18% of the company's stock.

WW International Company Profile

WW International, Inc NASDAQ: WW is a global wellness and weight management company that provides a range of subscription-based programs, digital tools and personalized coaching services. Originally founded in 1963 by Jean Nidetch as a small support group in New York City, the company grew into the well-known Weight Watchers brand before rebranding as WW in 2018 to reflect an expanded focus on overall health, fitness and nutrition. Over the years, WW has introduced innovations such as the SmartPoints® system, which assigns values to foods based on their nutritional composition, and the MyWW® personalized wellness plan, which tailors recommendations to individual lifestyles and goals.

WW's offerings span digital and in-person channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.